WAYNE GOODMAN to Combined Modality Therapy
This is a "connection" page, showing publications WAYNE GOODMAN has written about Combined Modality Therapy.
Connection Strength
0.700
-
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149.
Score: 0.129
-
Florida Obsessive-Compulsive Inventory: development, reliability, and validity. J Clin Psychol. 2007 Sep; 63(9):851-9.
Score: 0.056
-
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2007 Jul; 22(4):230-7.
Score: 0.055
-
Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: a case series of five patients. Depress Anxiety. 2007; 24(6):375-81.
Score: 0.053
-
Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol. 2006 Aug; 21(8):704-14.
Score: 0.052
-
Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: a network meta-analysis. J Child Psychol Psychiatry. 2024 05; 65(5):594-609.
Score: 0.043
-
Age moderated-anxiety mediation for multimodal treatment outcome among children with obsessive-compulsive disorder: An evaluation with correspondence analysis. J Affect Disord. 2021 03 01; 282:766-775.
Score: 0.035
-
Improving long term patient outcomes from deep brain stimulation for treatment-refractory obsessive-compulsive disorder. Expert Rev Neurother. 2020 01; 20(1):95-107.
Score: 0.033
-
Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder. J Anxiety Disord. 2020 01; 69:102151.
Score: 0.032
-
Obsessive-compulsive disorder: diagnosis and treatment. J Clin Psychiatry. 1999; 60 Suppl 18:27-32.
Score: 0.031
-
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510.
Score: 0.027
-
Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. J Psychiatr Res. 2015 Dec; 71:140-7.
Score: 0.025
-
Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behav Res Ther. 2013 Dec; 51(12):823-9.
Score: 0.021
-
Biological approaches to treatment-resistant obsessive compulsive disorder. J Clin Psychiatry. 1993 Jun; 54 Suppl:16-26.
Score: 0.021
-
Current treatment approaches to obsessive-compulsive disorder. Arch Psychiatr Nurs. 1991 Oct; 5(5):299-306.
Score: 0.019
-
A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2010 Dec 01; 68(11):1073-6.
Score: 0.018
-
Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder. Depress Anxiety. 2009; 26(1):E23-5.
Score: 0.015
-
A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
Score: 0.015
-
Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry. 2002 Feb; 159(2):263-8.
Score: 0.009
-
Inpatient treatment of patients with severe obsessive-compulsive disorder. Hosp Community Psychiatry. 1993 Dec; 44(12):1150-4.
Score: 0.005
-
The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis. Psychiatr Clin North Am. 1993 Dec; 16(4):749-66.
Score: 0.005